Predictive value of sST2,FGF-23 and sCD40L for cardiovascular events in patientson maintenance hemodialysis

Du Wei; Wang Li-li; Li Man

doi:10.3969/j.issn.1671-2390.m20-127

Journal of Clinical Nephrology > 2021 > 21(8): 648-653. > DOI: 10.3969/j.issn.1671-2390.m20-127

Du Wei, Wang Li-li, Li Man. Predictive value of sST2,FGF-23 and sCD40L for cardiovascular events in patientson maintenance hemodialysis[J]. Journal of Clinical Nephrology, 2021, 21(8): 648-653. DOI: 10.3969/j.issn.1671-2390.m20-127

Citation:

PDF (1020 KB)

Predictive value of sST2,FGF-23 and sCD40L for cardiovascular events in patientson maintenance hemodialysis

First Department of Nephrology, FourthMunicipal People's Hospital, Shenyang 110031, China

More Information

Received Date: October 26, 2020
Available Online: May 11, 2023
Published Date: August 27, 2021

Graphical Abstract

Abstract

Abstract

Objective To explore the predictive values of soluble growth-stimulation expressed gene protein 2(sST2), fibroblast growth factor 23(FGF-23) and soluble CD40 ligand(sCD40L) for the occurrence of cardiovascular events in patients on maintenance hemodialysis(MHD). Methods For this retrospective cohort study at a single center, 80 patients on MHD over 6 months between February 2015 and December 2019 were assigned into study group. They were followed up until June 2020. According to the presence or absence of cardiovascular events, they were divided into two groups of cardiovascular event(n=29) and non-cardiovascular event(n=51). During the same period, 40 healthy controls were selected as control group. The serum levels of sST2, FGF-23 and sCD40L were detected and compared among all groups. The relevant influencing factors of cardiovascular events were analyzed by univariate and multivariate Logistic regression analyses. The curves of receiver operating characteristic(ROC) were plotted for analyzing the predictive values of sST2, FGF-23 and sCD40L for cardiovascular events. Results The serum levels of sST2, FGF-23 and sCD40L were higher in study group than those in control group(P<0. 05). Age, dialysis age, levels of sST2, FGF-23 and sCD40L were higher in cardiovascular event group than those in non-cardiovascular event group(P<0. 05). Logistic regression analysis indicated that age ≥ 60 years, dialysis age ≥ 38 months and elevated levels of sST2, FGF-23 and sCD40L were independent risk factors of cardiovascular events in MHD patients(P<0. 05). And ROC curves revealed that area under curve(AUC) of serum levels of sST2 plus FGF-23 and sCD40L was 0. 901 for predicting cardiovascular events. It was higher than that of them alone(0. 769, 0. 752, 0. 728) (P<0. 05). Conclusion Elevated in MHD patients with cardiovascular events, the serum levels of sST2, FGF-23 and sCD40L have some predictive values for cardiovascular events.

FullText(HTML)

References (18)

References

[1]	赵俊丽, 张婷, 闵丹燕, 等.维持性血液透析患者血清骨硬化蛋白与冠脉钙化及心血管事件的关系[J]. 肾脏病与透析肾移植杂志, 2020, 29(3):208-214.DOI: CNKI:SUN:SZBY.0.2020-03-003. Zhao JL, Zhang T, Min DY, et al.Association of serum sclerostin with cardiovascular calcification and cardiovascular events in maintenance hemodialysis patients[J]. Chin J Nephrol Dial Transplant, 2020, 29(3):208-214.DOI: CNKI:SUN:SZBY.0.2020-03-003.
[2]	朱旻霞, 张伟明, 倪兆慧, 等.维持性血液透析患者透析期血压波动与透析相关并发症的相关性分析[J]. 上海交通大学学报(医学版), 2020, 40(4):484-488.DOI: 10.3969/j.issn.1674-8115.2020.04.011. Zhu MX, Zhang WM, Ni ZH, et al.Analysis of the correlation between blood pressure fluctuation and hemodialysis-related complications in patients with maintenance hemodialysis[J]. J Shanghai Jiaotong Univ Med Sci, 2020, 40(4):484-488.DOI: 10.3969/j.issn.1674-8115.2020.04.011.
[3]	朱士彦, 甘平, 吴楚海, 等.老年维持性血液透析患者心脏电生理变化与心血管疾病相关性[J]. 中国老年学杂志, 2019, 34(3):515-517.DOI: 10.3969/j.issn.1005-9202.2019.03.002. Zhu SY, Gan P, Wu CH, et al.Correlation between cardiac electrophysiological changes and cardiovascular disease in elderly patients with maintenance hemodialysis[J]. Chin J Gerontol, 2019, 34(3):515-517.DOI: 10.3969/j.issn.1005-9202.2019.03.002.
[4]	袁静, 王聪, 李恒, 等.维持性血液透析患者超滤率与心血管事件死亡的相关性[J]. 中华肾脏病杂志, 2018, 34(10):727-731.DOI: 10.3760/cma.j.issn.1001-7097.2018.10.002. Yuan J, Wang C, Li H, et al.Relationship between ultrafiltration rate and cardiovascular death in maintenance hemodialysis patients[J]. Chin J Nephrol, 2018, 34(10):727-731.DOI: 10.3760/cma.j.issn.1001-7097.2018.10.002.
[5]	刘涛, 靳宏敏, 杜荣品.血清FGF-23、cMyBP-C、sST2在急性心肌梗死患者中的表达及意义[J]. 中国循证心血管医学杂志, 2019, 11(7):818-820. Liu T, Jin HM, Du RP.Expression and significance of serum FGF-23, cMyBP-C and sST2 in patients with acute myocardial infarction[J]. Chin J Evid-Based Cardiovasc Med, 2019, 11(7):818-820.
[6]	杨慎先, 张艳霞.ACS患者血清sCD40L及PAPP-A水平与易损斑块的相关性[J]. 重庆医学, 2015, 44(10):1401-1403. Yang SX, Zhang YX.Correlation between serum sCD40L, PAPP-A levels and vulnerable plaques in ACS patients[J]. Chongqing Med, 2015, 44(10):1401-1403.
[7]	Watson CJ, Tea I, O'Connell E, et al.Comparison of longitudinal change in sST2 vs BNP to predict major adverse cardiovascular events in asymptomatic patients in the community[J]. J Cell Mol Med, 2020, 24(11):6495-6499.DOI: 10.1111/jcmm.15004.
[8]	方子美, 陈小芳, 余向东.血清FGF23、Fetuin-A检测对STEMI患者PCI术后发生MACE的预测价值[J]. 山东医药, 2019, 59(25):22-26. Fang ZM, Chen XF, Yu XD.Diagnostic value of serum FGF23 and Fetuin-A detection for MACE in patients with STEMI after PCI operation[J]. Shandong Med J, 2019, 59(25):22-26.
[9]	韩婷婷, 王虹, 吴美美, 等.sCD40L Lp-PLA2对行急诊PCI中发生心肌缺血/再灌注损伤评估价值[J]. 河北医学, 2020, 26(2):240-244. Han TT, Wang H, Wu MM, et al.Evaluation value of sCD40L and lp-PLA2 in myocardial ischemia/reperfusion injury during PCI[J]. Hebei Med, 2020, 26(2):240-244.
[10]	高翔, 苏华俊, 邓流飞, 等.血压变异性、氨基末端脑利钠肽前体与维持性血液透析患者心血管事件的相关性分析[J]. 临床肾脏病杂志, 2019, 19(1):49-53.DOI: 10.3969/j.issn.1671-2390.2019.01.010. Gao X, Su HJ, Deng LF, et al.Correlation between NT-proBNP and blood pressure variability with cardiovascular events in patients undergoing maintaining hemodialysis[J]. J Clin Nephrol, 2019, 19(1):49-53.DOI: 10.3969/j.issn.1671-2390.2019.01.010.
[11]	刘芳婕, 徐天华, 姚丽.维持性血液透析患者中血清同型半胱氨酸与心血管疾病相关性研究[J]. 中国实用内科杂志, 2018, 38(6):559-561.DOI: 10.19538/j.nk2018060117. Liu FJ, Xu TH, Yao L.Effects of plasma homocysteine on the cardiovascular disease in maintenance hemodialysis patients[J]. Chin J Pract Intern Med, 2018, 38(6):559-561.DOI: 10.19538/j.nk2018060117.
[12]	李明远, 陆国玉, 韩雨晴, 等.可溶性生长刺激表达基因2蛋白、半乳糖凝集素-3、B型钠尿肽联合检测对预测慢性心力衰竭不良预后的临床价值[J]. 临床检验杂志, 2020, 38(7):508-512.DOI: 10.13602/j.cnki.jcls.2020.07.07. Li MY, Lu GY, Han YQ, et al.Clinical value of combined detection of sST2, Galectin-3 and BNP in predicting poor prognosis of chronic heart failure[J]. Chin J Clin Lab Sci, 2020, 38(7):508-512.DOI: 10.13602/j.cnki.jcls.2020.07.07.
[13]	乐建华, 廖成标, 蒋爱忠, 等.肾功能正常的冠心病患者血清FGF-23与冠状动脉钙化的相关性[J]. 广东医学, 2020, 41(13):1352-1355.DOI: 10.13820/j.cnki.gdyx.20191570. Yue JH, Liao CB, Jiang AZ, et al.Correlation between serum FGF-23 and coronary artery calcification in asymptomatic coronary heart disease patients with preserved renal function[J]. Guangdong Med J, 2020, 41(13):1352-1355.DOI: 10.13820/j.cnki.gdyx.20191570.
[14]	李春伟, 李轶鹏, 秦文艳, 等.血清sCD40L联合NT-proBNP对心力衰竭的诊断及预后评估价值研究[J]. 中国实验诊断学, 2017, 21(5):816-819. Li CW, Li YP, Qin WY, et al.Value of serum sCD40L combined with NT-proBNP in the diagnosis and prognosis of heart failure[J]. Chin J Lab Diagn, 2017, 21(5):816-819.
[15]	邵博一, 娄明, 冯春光, 等.血清sST2、Lp-PLA2与冠心病经皮冠状动脉介入术后MACE事件发生的关系[J]. 心脑血管病防治, 2020, 20(2):211-213. Shao BY, Lou M, Feng CG, et al.The relationship between serum sST2, Lp-PLA2 and MACE events after percutaneous coronary intervention in coronary heart disease[J]. Cardio-Cerebrovasc Dis Prev Treat, 2020, 20(2):211-213.
[16]	姜立萍, 黄雯, 刘宁.维持性血液透析患者血浆可溶性CD40配体水平与心血管事件的关系研究[J]. 中国全科医学, 2011, 14(3):236-238. Jiang LP, Huang W, Liu N.Relationship between soluble CD40 ligand level and cardiovascular events in maintenance hemodialysis patients[J]. Chin Gen Pract, 2011, 14(3):236-238.
[17]	Altara R, Ghali R, Mallat Z, et al.Conflicting vascular and metabolic impact of the IL-33/sST2 axis[J]. Cardiovasc Res, 2018, 114(12):1578-1594.DOI: 10.1093/cvr/cvy166.
[18]	邢文, 赵春梅, 王德国.血清成纤维细胞生长因子23与慢性心力衰竭心室重构的相关性[J]. 临床心血管病杂志, 2016, 32(1):36-39.DOI: 10.13201/j.issn.1001-1439.2016.01.009. Xing W, Zhao CM, Wang DG.Correlation of serum FGF23 levels and ventricular remodeling in patients with chronic heart failure[J]. J Clin Cardiol, 2016, 32(1):36-39.DOI: 10.13201/j.issn.1001-1439.2016.01.009.

Cited By

Cited by

Periodical cited type(5)

1.	吕宁，杨立娟，尹林林，王丹，宴俊芳. 血清可溶性CD40配体、腱糖蛋白C、甲壳质酶蛋白-40联合检测对维持性血液透析并发心血管事件的预测作用. 陕西医学杂志. 2025(01): 123-126+137 .
2.	刘杨艳，刘李林，骆静. 冠状动脉介入术对维持性血液透析合并冠心病患者的影响研究. 安徽医专学报. 2024(06): 29-31 .
3.	李术环，李宏彬. 全段甲状旁腺激素水平在预测老年血液透析患者心脑血管事件中的作用. 中国临床保健杂志. 2023(03): 380-384 .
4.	雷爱丽，刘卫永，赵俊涛. 血清FGF-23、FGF-21、IGF-1与维持性血液透析患者冠状动脉钙化及心血管事件的相关性. 中国现代医药杂志. 2023(12): 44-48 .
5.	韩媛媛，张菁菁，穆福娜依，冒智捷，张丽. 西那卡塞联合碳酸司维拉姆对血液透析并发继发性甲状旁腺功能亢进患者钙磷代谢、FGF23/Klotho轴和心血管事件的影响. 现代生物医学进展. 2022(07): 1277-1281 .

Other cited types(1)

Get Citation

PDF

XML

Article views (225) PDF downloads (215) Cited by(6)

Turn off MathJax

Article Contents

Abstract

References

Predictive value of sST2,FGF-23 and sCD40L for cardiovascular events in patientson maintenance hemodialysis

Abstract

References

Cited by

Periodical cited type(5)

Other cited types(1)

Catalog

Export File

Citation

Format

Content